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Purpose: Ischemic time (IT) is an independent risk factor for poor functional 
exercise capacity (FEC) following orthotopic heart transplantation (OHT). The OHT 
recipient’s post-transplant FEC (peak VO2) is directly associated with improved quality 
of life. However, there is debate in the literature about the deleterious impact of extended 
IT on FEC following OHT.  
Methods: Fifteen OHT recipients (14 men and 1 woman; < 3 months from OHT) 
performed a symptom-limited graded CPET where peak VO2 was measured in an 
outpatient cardiac rehabilitation. IT was obtained from the anesthesia post-operative note. 
VO2 and IT values were dichotomized based on previous literature; high, ≥14 mL/kg/min 
(or ≥12 mL/kg/min if taking a beta blocker), and low, <14 mL/kg/min (or <12 
mL/kg/min if taking a beta blocker), and short, <180 min and long, ≥180 min, 
respectively. A Fisher’s Exact Test was used to determine if extended IT is associated 
with decreased FEC.  
Results: The median (IQR) recipient and donor characteristics are presented in 
Table 3. The Fisher’s Exact Test yielded a p value of 0.62.  
iv 
 Conclusions: Extended IT was not associated with decreased FEC in the months 
following OHT in those recipients who survived to discharge with stamina sufficient to 
engage in outpatient cardiac rehabilitation. The wider IQR of peak VO2 in recipients with 
extended IT, despite the higher number of recipients, suggests that while properly 
selected allografts are able to tolerate a longer IT without compromising intermediate 
term FEC, this is not a homogenous correlation and other peri-transplant factors may 
modify FEC.  
v 
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Chapter 1 
Introduction and Background 
Orthotopic Heart Transplantation (OHT) 
As the battle against the nation’s leading cause of death, heart disease, continues 
to expand, orthotopic heart transplantation (OHT) remains a feasible option for the 
treatment of end-stage heart failure (HF). OHT is the current gold standard for the 
treatment of HF due to its potential to extend the life of the recipient, improve the 
recipient’s quality of life (QOL), and functional capacity.1 Furthermore, OHT has been 
more effective in decreasing mortality and improving QOL in comparison to alternative 
HF treatments such as Left Ventricular Assist Device (LVAD) or medical management.2 
More than 70,000 OHTs have been performed since 19883 and, due to advancements in 
technology, the number per year is steadily increasing.4  
Transplant Donor Guidelines and Organ Procurement 
As more patients require OHT, the demand for suitable donor hearts is likely to 
increase and currently outweighs the supply of available donor organs. In order to 
accommodate the need for eligible donor hearts, many institutions are working to expand 
the criteria for what constitutes an acceptable donor heart. Since OHT outcomes are 
complex and multifaceted, multiple donor qualities and organ procurement and 
preservation techniques have been reexamined in the hopes of improving the accessibility 
of OHT. Donor characteristics, such as age and previous health status, have been a 
growing topic of interest for years, ultimately allowing for an expansion in the donor 
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pool. For example, in the late 1980’s, donor hearts were only deemed transplantable if the 
donor was younger than 35 years of age for men and 40 years of age for women.5 
Recently, however, research has explored the implications of transplanting older donor 
hearts and older recipients but no age limit has been established.6, 7  
In addition to donor specific qualities, investigation into donor heart preservation 
and procurement guidelines has allowed for potential change in the previous donor organ 
requirements. For example, OHT clinicians have suggested that by increasing the time 
allowable for a donor heart to reach its destination, donor hearts may become accessible 
to people in more remote locations (or the most ill nationwide/worldwide). However, 
more distant destinations may require the donor heart to remain under-perfused for longer 
periods of time. This characteristic of donor heart preservation, called ischemic time (IT), 
is currently under investigation. Longer IT may allow for increased availability of donor 
hearts, but the implications of extended IT are not fully understood. 
 
Heart Ischemic Time (IT) 
 Heart IT is defined as “the time that an organ is outside the body when the heart 
is not beating and/or supplied with oxygen by the coronary arteries.”8 According to 
traditional research and guidelines, is ideal when IT is less than 240 minutes.5,7 However, 
some institutions remain more conservative with idealistic IT of 180 minutes or less.9 
While some studies have found that IT is an independent risk factor for mortality and 
poor prognosis following OHT,10,11 other studies suggest that extended IT has no impact 
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on long term survival.12 Moreover, several case studies have investigated donor IT of up 
to six hours (360 minutes) with no difference in mortality up to 36 months post-
transplant.13 In regards to post-surgical complications and resource allocation, one study 
suggested that there is no difference in the risk for primary graft dysfunction, length of 
hospital stay, need for inotropic or ventilatory support or rejection associated with donor 
IT of less than 4 hours and 4 to 5 hours, but the risk begins to increase after 5 hours.10 
Although there are interventions being explored to minimize the ischemic damage of 
donor hearts with prolonged IT14, there is still ongoing discussion as to what constitutes a 
suitable IT for OHT. 
Ischemic Time and Functional Exercise Capacity (FEC) 
As there is ongoing debate in the literature regarding long-term impact of 
prolonged IT on patients with OHT, it is imperative to understand the impact IT has on 
the donor heart’s capacity to do work after OHT. It has been suggested that patients 
experience a decreased exercise capacity following OHT when compared to healthy 
individuals,14,15 which impacts the overall functional exercise capacity (FEC) of the OHT 
recipient. FEC is a significant component in an individual’s ability to perform activities 
of daily living, participate in recreational and occupational ventures and is associated 
with QOL after OHT.2 Low QOL has been associated with increased symptoms of 
depression and anxiety in OHT recipients16, which makes it imperative for healthcare 
professionals to understand the impact prolonged IT may have on the recipient’s 
prognosis.  
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Given that increased IT may impact cardiac functioning following adult OHT, the 
impact of IT on FEC should warrants further investigation in order to further understand 
the implications of using donor hearts with extended IT. In one landmark study, shorter 
IT was related to increased FEC in OHT recipients two months post-transplant, but this 
study was not sensitive to the variable needs of the OHT patient population.16 This 
particular study estimated the patients’ FEC merely by the number of metabolic 
equivalents (METs) they were able to achieve, without the use of metabolic-cart gas 
analysis, on a Bruce treadmill protocol. Although, this study provides valuable 
information; it is not inclusive of the many OHT recipients that may be unable to perform 
this test due to orthopedic limitations, severe deconditioning observed with end-stage 
heart failure, and the large increase in speed and incline with each progressive stage.   
Therefore, in order to create a more inclusive and specific investigation into the 
impact of prolonged IT on FEC, a symptom-limited, cardiopulmonary exercise test 
(CPET) should be used involving a modality and protocol best suited for the individual 
patient.  
 
Purpose 
The purpose of this study was to investigate the effect that donor IT has on FEC, 
measured by peak volume of oxygen consumption (VO2), in adults after OHT. 
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Chapter 2 
Methods 
 
Study Design 
 
  A prospective, observational study was performed on 15 OHT recipients between 
January 2019 and October 2019 who were enrolled at the Walter I. Berman 
Cardiovascular Rehabilitation (CR) and Prevention Center at Baylor Scott and White 
Heart and Vascular Hospital in Dallas, Texas. All subjects enrolled were 
hemodynamically stable adult outpatients who underwent OHT fewer than 90 days 
before enrollment in the study.  
Inclusion and Exclusion Criteria Table 1 provides the inclusionary and 
exclusionary criteria for the study. 
 
Table 1. Inclusion and Exclusion Criteria for Patient Enrollment 
Inclusion Criteria Exclusion Criteria 
Male or female 
Hemodynamically stable 
Outpatient enrolled in cardiac rehabilitation  
Recipient of OHT within three months from 
enrollment date 
18 to 80 years of age 
Able to read and understand an informed consent 
 
Orthopedic, neurologic or other limitations that 
prevent exercise testing on a treadmill or cycle 
ergometer 
Requiring supplemental oxygen  
Current permanent tracheostomies  
Patients discharged to a long-term acute care 
facility; skilled nursing facility or with 
palliative/hospice care  
Inmates 
Pregnant women 
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Subject Identification 
 
Potential subjects were identified upon admission to the CR program by use of a 
screening tool illustrating inclusion and exclusion criteria. Patients who met the inclusion 
criteria were offered participation in the study and if agreeable, were taken through the 
informed consent process during their first day of CR. 
 
Cardiopulmonary Exercise Testing (CPET) 
 
An order requesting a CPET was signed and dated by the subject’s cardiothoracic 
transplant surgeon, cardiologist, appropriately licensed advanced practice healthcare 
provider with heart transplant expertise, or primary care physician. Upon admission to the 
CR program, subjects were scheduled to perform a CPET on either an upright cycle 
ergometer or treadmill depending on level of comfort and fall risk assessment performed 
by a registered nurse on the day of testing. Subjects were fitted for metabolic testing 
(Quark CPET, COSMED, Concord, CA or similar) equipment according to factory 
requirements and a lead II ECG monitor was attached to the subject (ScottCare 
VersaCare Telemetry Monitoring System, Cleveland, Ohio or similar) to monitor for 
arrythmias. Each subject was asked to perform the CPET to the best of their abilities. The 
modified Borg Rating of Perceived Exertion (RPE-CR10) scale was used during the 
testing.17 The RPE-CR10 (1 to 10) scale is a common method for determining exercise 
intensity levels, where “0” = nothing at all and “10” = very, very hard. The traditional 
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Borg scale (6-20) was not used due to the disassociation between level of difficulty and 
heart rate seen in a denervated heart. Continuous blood pressure (BP) measurements were 
taken to ensure hemodynamic stability and lead II ECG was monitored continuously by 
telemetry staff.  
 
Termination Criteria 
 
The CPET was terminated if any of the following occurred: (a) subject became 
symptomatic; (b) increased pain reported; (c) subject asked to terminate test; (d) 
dangerous arrhythmias reported on ECG; (e) unsafe drop in BP or over 250/120 mmHg 
reported; or (f) subject reported a “10” on RPE-CR10 scale, indicating maximal effort. 
Other termination of the test was reserved for the clinical judgment of research staff to 
ensure safety of the subject. After termination of the test, subject was instructed to 
perform a cool-down of 3 to 5 minutes. The CPET was performed in an area with 
immediate access to a “crash cart”, a supervising physician, and clinical staff trained in 
advanced cardiac life support. Donor organ-specific data was gathered through the UNOS 
Donor Infection ID and Match Run and matched with the corresponding printed CPET 
report after completion of the test. 
 
Statistical Analysis  
 The main exposure of this study was duration of IT. The overall median inter 
quartile range (IQR) of IT were calculated according to standard methods. IT was further 
dichotomized into longer and shorter IT using cutoff of 180 minutes.9,18 The main 
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outcome of this study was the subject’s FEC, measured by peak VO2, which was 
dichotomized into lower and higher FEC using a pre-specified cutoff of 14 mL/kg/min 
and a pre-specified supplemental analysis was performed using a dichotomous cutoff of 
12 mL/kg/min. These two cut-offs were selected as they represent the standard thresholds 
below which transplant is most typically justified in an ambulatory, non-inodilator-
dependent subject (14 mL/kg/min for pre-transplant patients without current beta blocker 
use and 12 mL/kg/min with beta blocker use).9,17 Data are shown as percentages or n for 
categorical variables and compared between subjects with lower FEC and those with 
higher FEC using a Fisher’s Exact Test; medians IQR for continuous variables were 
calculated according to standard methods. Data were analyzed using NCSS 11 (NCSS, 
LLC - Kaysville, UT). 
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Chapter 3 
Results 
Patient Characteristics  
 The patient demographics and characteristics information for this cohort can be 
depicted in Table 2 below.  
 
Table 2. Patient Characteristics Demographics  
Characteristics/Demographics Median (IQR) or % 
Age (years) 
Height (cm) 
Body weight (kg) 
Resting HR (bpm) 
Asian 
Black 
Hawaiian 
White 
Hispanic  
Fall Risk 
Modified “Slow” USAFSAM 
Beta Blocker Use 
58 (10.7) 
175.26 (7.37) 
83.46 (16.92) 
112 (10) 
6.67% 
20.00% 
6.67% 
66.67% 
6.67% 
46.6% 
53.33% 
6.67% 
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Comparison of IT and FEC 
 
  The comparison between the long IT and short IT groups as well as the High FEC 
and Low FEC groups is detailed in Table 3 and visualized in Figure 1. The results of the 
Fisher’s Exact Tests yielded a p value of 0.62.  
 
Table 3. Median (IQR) Donor and Recipient Characteristics Comparing IT and FEC 
 Long IT Short IT Total 
Donor age (years)   
Recipient age (years) 
IT (minutes) 
VO2 (mL/kg/min) 
High FEC 
Low FEC 
45 (31) 
60 (14) 
249 (46) 
14.4 (7.0) 
n= 6 
n= 3 
38 (13) 
65 (12) 
115 (52) 
14.0 (3.6) 
n= 3 
n= 3 
42 (26) 
60 (10) 
224 (148) 
14.4 (4) 
15.8 (3.3) 
11.3 (2.7) 
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Figure 1. Box Plot of Median Peak VO2 in Long and Short Ischemic Time Categories   
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Chapter 4 
Conclusions and Implications  
Interpretation of Results 
 
According to the analysis performed in this cohort, extended IT (>180 minutes) 
was not associated with decreased FEC (<14 mL/kg/min or <12 mL/kg/min with beta 
blocker use) in the months following OHT in recipients who survived to discharge with 
stamina sufficient to engage in an outpatient CR program. The wider IQR of peak VO2 in 
OHT recipients with extended IT, despite the higher number of recipients, suggests that 
while properly selected allografts can tolerate a longer IT without compromising 
intermediate term FEC, this is not a homogenous correlation and other peri-transplant 
factors may modify FEC.  
 
Comparison of Results to the Literature  
These results do not support the findings of Buendia-Fuentes et. al., regarding 
donor and recipient specific qualities that impact functional recovery in the 2 months 
following transplant.16 This discrepancy may be in part due to the method used to test and 
evaluate OHT recipients. Those investigators, used the Bruce treadmill protocol, which 
utilizes steep incline and speed increases each progressing stage. Functional capacity was 
also estimated using METs, which are not representative of this population due to an 
abnormal response to exercise.15,18 Since breath-by-breath gas analysis and a more 
individualized testing modality were used in the present study, this may more accurately 
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reflect their actual peak VO2. For subjects that did not present as a fall risk, a modified 
USAFSAM treadmill protocol (for CHF patients) was used and for those who were 
deemed unsafe to perform a CPET on a treadmill, a 10 W ramp cycle ergometer protocol 
was used.19 Future studies, might need to analyze differences that may exist between 
cycle ergometry and treadmill outcomes in this clinic population, as we know that VO2 
may be underestimated in cycle ergometry testing.20  
Limitations 
  Although the results of the present study provide valuable insight into the 
relationship between donor IT and the ability of the transplanted heart to do work in the 3 
months immediately following surgery, it is not without limitations, particularly due to 
the small size. Due to the United Network for Organ Sharing’s revision to the adult heart 
allocation policy in October 2018, an increased percentage of OHT recipients required 
placement post-discharge from the acute-care setting and consequently were ineligible to 
participate in the study.21 The increasing accessibility of extracorporeal membrane 
oxygenation and temporary mechanical circulatory support devices (Impella, intra-aortic 
balloon pump, etc.), allowing the most critical patients to survive until transplant, resulted 
in additional orthopedic and neurologic limitations that restricted exercise testing. 
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Future Recommendations 
The investigation into the effect extended IT has on FEC after OHT could be 
strengthened by a larger sample, across multiple transplant centers, with a longitudinal 
analysis to account for effect of IT on long-term functional allograft recovery. Due to the 
variation in results in the literature surrounding the possible impact of increasing IT on 
the immediate and long-term allograft function post OHT, in addition to the association 
between FEC and QOL, further investigation is warranted exploring the impact of longer 
IT.  
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